Conservative Management for Adolescent Idiopathic Scoliosis
Launched by UMM AL-QURA UNIVERSITY · Apr 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment approach for adolescents with idiopathic scoliosis, a condition where the spine curves abnormally, and the cause is unknown. The researchers believe that understanding and addressing the muscle and nerve functions might help correct the curvature more effectively than traditional methods. They are looking for young people aged 10 to 17 who have been diagnosed with mild scoliosis, specifically those whose spine curvature, measured by a method called the Cobb angle, falls between 10 and 25 degrees.
To participate in the trial, candidates must be generally healthy apart from their scoliosis and should not have any serious neurological or nutritional disorders. They also need to be able to understand and communicate well. If selected, participants can expect to undergo a treatment regimen aimed at improving their spinal curvature without the need for surgery. It’s important to note that this study is currently recruiting participants, so there is an opportunity to contribute to developing a potentially better treatment for scoliosis in adolescents.
Gender
ALL
Eligibility criteria
- The inclusion criteria will be:
- • Adolescents of both sexes with an age range between 10-17 years.
- • They were diagnosed with Adolescent idiopathic scoliosis by an orthopedic specialist, confirmed through (loaded) X- rays.
- • They have mild non-structural scoliosis with Cobb's angle measurement of between 10 and 25 degrees
- • They have Single major thoracolumbar curve located between T6-7 to L1-2, apex at T12 or L1.
- • They have good health conditions except for scoliosis.
- • They can understand and communicate with no mental abnormalities.
- The exclusion criteria will be:
- • Adolescents with cerebral palsy or other degenerative neurological disorders;
- • Participants with nutritional disorders e.g. diabetes or vascular disorders.
- • Participants with a scoliotic curve with angle \> 25° will be excluded.
- • Participants will be excluded from this study if they have inflexible spinal deformities interfering with spinal mobility,
- • Participants who were subjected to any corrective surgery to their spine within the previous two years.
- • Participants will be also excluded if their skin were sensitive or inflamed to any materials used.
- • Participants who have seizures, perceptual disorders, visual problems, and auditory deficits
- • Participants who have leg length discrepancy
- • Participants who have scoliosis developed as a consequence of traumatic scoliosis.
About Umm Al Qura University
Umm Al-Qura University, located in Mecca, Saudi Arabia, is a prestigious institution dedicated to advancing education and research across various disciplines, including health sciences. As a clinical trial sponsor, the university is committed to fostering innovative research initiatives that contribute to the understanding and treatment of medical conditions. By leveraging its academic resources and expertise, Umm Al-Qura University aims to enhance clinical practices and improve patient outcomes through rigorous scientific investigation and collaboration with healthcare professionals and institutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mecca, , Saudi Arabia
Patients applied
Trial Officials
Ehab M Abd El Kafy, PhD
Principal Investigator
Department of Physical Therapy- Faculty of Applied Medical Sciences - Umm Al Qura University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported